Skip to content

Posts by Clemens R. Scherzer, MD

  • As part of an international consortium, Massachusetts General Hospital neurologists helped identify three genetic loci, and confirm two others, that influence time to progression to dementia in Parkinson's disease, and devised a polygenic score that predicts which PD patients are likely to rapidly develop dementia.


Dr. Scherzer is an Associate Professor of Neurology at Harvard Medical School and directs the Laboratory for Neurogenomics. He is the Coordinating Principal Investigator of the Global Parkinson's Disease Gene Expression Consortium (GPEX). He received the Paul B. Bees on Awar d of the American Federation for Aging Research and the National Institute on Aging, and a Dr. George Cotzias Memorial Award of the American Parkinson's Disease Association. He completed neurology residency at Emory University and fellowship training in movement disorders and in genomics at Massachusetts General Hospital and Harvard Medical School. In his clinical practice he works as a movement disorders specialist at Brigham and Women's Hospital and Massachusetts General Hospital, and is the Co-Director of the Harvard NeuroDiscovery Biomarker Study.